AARTISURF
Aarti Surfactants Limited
Home and personal care ingredients and specialty intermediates manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
aarti-surfactants.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Aarti Surfactants makes surfactants and speciality chemicals sold as home and personal care ingredients, from manufacturing units in Silvassa and Pithampur.
Company snapshot
53rdBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓95% of operating profit came in as cash over the last three years — profits are backed by real cash.
- ✗Net margin is very thin at 1.4% — little room for error if costs rise.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 144 Cr | 139 Cr | 159 Cr | 143 Cr | 151 Cr | 163 Cr | 202 Cr | 216 Cr | 179 Cr | 208 Cr | 256 Cr | 273 Cr |
| Operating expenses (approx.) | 128 Cr | 122 Cr | 144 Cr | 134 Cr | 147 Cr | 154 Cr | 182 Cr | 204 Cr | 170 Cr | 195 Cr | 243 Cr | 253 Cr |
| EBITDA | 16 Cr | 17 Cr | 14 Cr | 10 Cr | 4 Cr | 9 Cr | 20 Cr | 12 Cr | 9 Cr | 13 Cr | 13 Cr | 20 Cr |
| OPM % | 11.3% | 12.1% | 9.0% | 6.7% | 2.5% | 5.5% | 9.7% | 5.4% | 5.2% | 6.1% | 5.2% | 7.4% |
| Other income | 0.03 Cr | 0.03 Cr | 0.05 Cr | 0.49 Cr | 2 Cr | -0.16 Cr | 1 Cr | 0.04 Cr | 0.06 Cr | 0.04 Cr | 0.19 Cr | 0.17 Cr |
| Interest | 4 Cr | 4 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr |
| Depreciation | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 5 Cr |
| Profit before tax | 9 Cr | 9 Cr | 7 Cr | 3 Cr | 3 Cr | 1 Cr | 13 Cr | 4 Cr | 2 Cr | 5 Cr | 6 Cr | 12 Cr |
| Tax % | 45.9% | 26.4% | 29.7% | 33.0% | 40.0% | 34.0% | 26.2% | 27.2% | 29.1% | 28.3% | 28.8% | 26.2% |
| Net profit | 5 Cr | 7 Cr | 5 Cr | 2 Cr | 2 Cr | 0.80 Cr | 10 Cr | 3 Cr | 2 Cr | 4 Cr | 4 Cr | 9 Cr |
| EPS (₹) | ₹5.97 | ₹8.42 | ₹5.81 | ₹2.62 | ₹2.14 | ₹0.95 | ₹11.50 | ₹3.48 | ₹1.84 | ₹4.32 | ₹4.95 | ₹10.63 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 466 Cr | 576 Cr | 601 Cr | 590 Cr | 659 Cr | 859 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 420 Cr | 543 Cr | 554 Cr | 528 Cr | 617 Cr | 812 Cr | Sign in free for the trailing twelve months |
| EBITDA | 46 Cr | 32 Cr | 48 Cr | 62 Cr | 42 Cr | 47 Cr | Sign in free for the trailing twelve months |
| OPM % | 9.8% | 5.6% | 7.9% | 10.5% | 6.4% | 5.5% | Sign in free for the trailing twelve months |
| Other income | 0.06 Cr | 0.29 Cr | 0.33 Cr | 0.13 Cr | 3 Cr | 0.33 Cr | Sign in free for the trailing twelve months |
| Interest | 10 Cr | 11 Cr | 15 Cr | 14 Cr | 12 Cr | 12 Cr | Sign in free for the trailing twelve months |
| Depreciation | 12 Cr | 12 Cr | 15 Cr | 16 Cr | 17 Cr | 18 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 23 Cr | 9 Cr | 18 Cr | 32 Cr | 21 Cr | 17 Cr | Sign in free for the trailing twelve months |
| Tax % | 5.6% | 41.0% | 29.1% | 33.4% | 29.7% | 28.3% | Sign in free for the trailing twelve months |
| Net profit | 22 Cr | 5 Cr | 13 Cr | 21 Cr | 15 Cr | 12 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹28.52 | ₹7.24 | ₹16.64 | ₹26.63 | ₹17.20 | ₹14.59 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 41.1% | -0.0% | 0.0% | 0.0% | 6.9% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr |
| Reserves | 125 Cr | 128 Cr | 160 Cr | 210 Cr | 224 Cr | 236 Cr |
| Borrowings | 146 Cr | 162 Cr | 149 Cr | 97 Cr | 109 Cr | 103 Cr |
| Other liabilities | 106 Cr | 105 Cr | 85 Cr | 107 Cr | 136 Cr | 169 Cr |
| Total liabilities | 384 Cr | 402 Cr | 402 Cr | 422 Cr | 477 Cr | 517 Cr |
| Fixed assets (net) | 186 Cr | 172 Cr | 207 Cr | 206 Cr | 202 Cr | 198 Cr |
| CWIP | 20 Cr | 52 Cr | 8 Cr | 7 Cr | 13 Cr | 41 Cr |
| Investments | 0 Cr | 0.0003 Cr | 0 Cr | 0.0003 Cr | 0.0005 Cr | 0.0005 Cr |
| Loans & advances | 0 Cr | 0.20 Cr | 0.12 Cr | 0.12 Cr | 0.14 Cr | 0.27 Cr |
| Inventories | 73 Cr | 75 Cr | 77 Cr | 99 Cr | 134 Cr | 119 Cr |
| Trade receivables | 54 Cr | 54 Cr | 65 Cr | 70 Cr | 76 Cr | 105 Cr |
| Cash & bank | 7 Cr | 1 Cr | 8 Cr | 6 Cr | 0.86 Cr | 12 Cr |
| Other assets | 44 Cr | 47 Cr | 37 Cr | 33 Cr | 51 Cr | 42 Cr |
| Total assets | 384 Cr | 402 Cr | 402 Cr | 422 Cr | 477 Cr | 517 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 36 Cr | 23 Cr | 25 Cr | 52 Cr | 15 Cr | 77 Cr |
| Cash from investing | -61 Cr | -23 Cr | 9 Cr | -16 Cr | -20 Cr | -46 Cr |
| Cash from financing | 32 Cr | -6 Cr | -27 Cr | -37 Cr | -0.37 Cr | -19 Cr |
| Net cash flow | 7 Cr | -5 Cr | 6 Cr | -1 Cr | -5 Cr | 12 Cr |
| Free cash flow (OCF − Capex) | -26 Cr | 0.78 Cr | 14 Cr | 36 Cr | -5 Cr | 32 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 12.0% | 6.7% | 10.3% | 14.6% | 9.4% | 8.5% |
| ROE % | 16.3% | 4.0% | 7.6% | 9.8% | 6.3% | 5.0% |
| Debtor days | 43 | 34 | 40 | 43 | 42 | 44 |
| Inventory days | 75 | 59 | 60 | 81 | 90 | 60 |
| Days payable | 80 | 55 | 44 | 55 | 62 | 62 |
| Cash conversion cycle | 38 | 38 | 55 | 70 | 70 | 42 |
| OCF / EBITDA % | 78.7% | 72.5% | 51.9% | 83.6% | 36.6% | 163.5% |
| OCF / EBITDA % (3 years) | — | — | 66.9% | 70.5% | 60.7% | 95.4% |
| Debt / equity | 1.10 | 1.19 | 0.89 | 0.45 | 0.47 | 0.42 |
| Current ratio | 1.12 | 1.17 | 1.26 | 1.54 | 1.35 | 1.32 |
| Net debt / EBITDA | 3.06 | 4.98 | 2.96 | 1.46 | 2.57 | 1.93 |